India’s Aurobindo Pharma Weighs Spin-Off Of API, Formulation Unit
This article was originally published in PharmAsia News
Executive Summary
Aurobindo Pharma of India said it is considering a spin-off of a unit that makes active pharmaceutical ingredients and formulations